« Zurück
Home /
vandetanib-hydrochloride

vandetanib-hydrochloride

Hersteller	InvivoChem LLC
Kategorie	Reagents & Chemicals Molecules
Typ	Biochemicals
Specific against	other
Menge	100mg
ArtNr	V30291-100mg
CAS-Nr.	524722-52-9
eClass 6.1	32160405
eClass 9.0	32160490
Lieferbar
Description	InvivoChem Cat #:V30291CAS #:524722-52-9Purity >=98% Description: Vandetanib hydrochloride (formerly also known as ZD6474) is a novel, highly potent, orallybioavailable, selective inhibitor of VEGFR2 with IC50 of 40 nM in acell-free assay. Vandetanib selectively inhibits the tyrosine kinaseactivity of vascular endothelial growth factor receptor 2 (VEGF2), thereby blocking VEGF-stimulated endothelial cell proliferation andmigration and reducing tumor vessel permeability. The inhibition ofVEGFR-2 was 2.7-fold more potent than that of VEGFR-3 (Flt-4) kinase and40-fold more potent than that of VEGFR-1. In human umbilical veinendothelial cells, treatment of ZD6474 resulted in significantinhibition of cell proliferation stimulated by VEGF and EGF with IC50values of 60 and 170 nM, respectively. References: Cancer Res. 2002 Aug 15; 62(16):4645-55; Clin Cancer Res. 2012 Jul 15; 18(14):3924-33; Clin Cancer Res. 2003 Apr; 9(4):1546-56. Related CAS: 338992-00-0 (fumarate); 524722-52-9 (HCl salt); 338992-53-3 (trifluoroacetate); 443913-73-3 (free base) Description: Vandetanib hydrochloride (formerly also known as ZD6474) is a novel, highly potent, orallybioavailable, selective inhibitor of VEGFR2 with IC50 of 40 nM in acell-free assay. Vandetanib selectively inhibits the tyrosine kinaseactivity of vascular endothelial growth factor receptor 2 (VEGF2), thereby blocking VEGF-stimulated endothelial cell proliferation andmigration and reducing tumor vessel permeability. The inhibition ofVEGFR-2 was 2.7-fold more potent than that of VEGFR-3 (Flt-4) kinase and40-fold more potent than that of VEGFR-1. In human umbilical veinendothelial cells, treatment of ZD6474 resulted in significantinhibition of cell proliferation stimulated by VEGF and EGF with IC50values of 60 and 170 nM, respectively. References: Cancer Res. 2002 Aug 15; 62(16):4645-55; Clin Cancer Res. 2012 Jul 15; 18(14):3924-33; Clin Cancer Res. 2003 Apr; 9(4):1546-56. Related CAS: 338992-00-0 (fumarate); 524722-52-9 (HCl salt); 338992-53-3 (trifluoroacetate); 443913-73-3 (free base) Description: Vandetanib hydrochloride (formerly also known as ZD6474) is a novel, highly potent, orallybioavailable, selective inhibitor of VEGFR2 with IC50 of 40 nM in acell-free assay. Vandetanib selectively inhibits the tyrosine kinaseactivity of vascular endothelial growth factor receptor 2 (VEGF2), thereby blocking VEGF-stimulated endothelial cell proliferation andmigration and reducing tumor vessel permeability. The inhibition ofVEGFR-2 was 2.7-fold more potent than that of VEGFR-3 (Flt-4) kinase and40-fold more potent than that of VEGFR-1. In human umbilical veinendothelial cells, treatment of ZD6474 resulted in significantinhibition of cell proliferation stimulated by VEGF and EGF with IC50values of 60 and 170 nM, respectively. Description: References: Cancer Res. 2002 Aug 15; 62(16):4645-55; Clin Cancer Res. 2012 Jul 15; 18(14):3924-33; Clin Cancer Res. 2003 Apr; 9(4):1546-56. References:

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkdatenblatt anfordern

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 100mg

lieferbar

Lieferung vsl. bis 02.08.2024

Express-Lieferung: 7 Tage sparen

Vergleichen

Auf den Wunschzettel

Weiterempfehlen per Mail